XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders’ Equity
 9 Months Ended
Dec. 31, 2021
Statement of Stockholders' Equity [Abstract]  
Stockholders’ Equity

Note 17 — Stockholders’ Equity 

 

Issuance of Restricted Shares of Common Stock for Services to Consultants and Vendors

 

During the nine months ended December 31, 2021, the Company incurred $0.3 million in accounts payable and accrued liabilities for stock earned by its consultants, but not yet issued. The remaining unrecognized compensation cost of less than $0.1 million is expected to be recorded over the next year as the shares vest.

 

During the nine months ended December 31, 2020, the Company incurred $1.0 million in accounts payable and accrued liabilities for stock earned by its consultants, but not yet issued.

  

2016 Equity Incentive Plan

 

The Company’s board of directors and stockholders approved the Company’s 2016 Equity Incentive Plan, as amended (the “2016 Plan”) which reserved a total of 12,600,000 shares of the Company’s common stock for issuance. On September 17, 2020, our stockholders approved the amendment to the 2016 Plan to increase the number of shares available for issuance under the plan by 5,000,000 shares increasing the total up to 17,600,000 shares, which plan we formally increased on June 29, 2021. Incentive awards authorized under the 2016 Plan include, but are not limited to, nonqualified stock options, incentive stock options, restricted stock awards, restricted stock units, performance grants intended to comply with Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), and stock appreciation rights. If an incentive award granted under the 2016 Plan expires, terminates, is unexercised or is forfeited, or if any shares are surrendered to the Company in connection with the exercise of an incentive award, the shares subject to such award and the surrendered shares will become available for further awards under the 2016 Plan.

 

The Company recognized share-based compensation expense of $12.1 million and $8.0 million during the nine months ended December 31, 2021 and 2020, respectively, and $2.1 million and $2.7 million during the three months ended December 31, 2021 and 2020, respectively. The total tax benefit recognized related to share-based compensation expense was $0 for the three and nine months ended December 31, 2021 and 2020, respectively.

 

Share-based compensation expense during the three and nine months ended December 31, 2021 and 2020 includes the impact from differences in the timing of expense recognized in the statement of operations and the share issuances recorded in additional paid in capital, capitalization of internally developed software costs, and the benefit from the reversal of a previously accrued discretionary share-based award bonus of $1.1 million during the three months ended December 31, 2021.